John Mellors
Chief Executive Officer at Abound Bio, Inc.
Profile
John Mellors is the founder of Infectious Disease Connect, Inc.
John Mellors active positions
| Companies | Position | Start |
|---|---|---|
Abound Bio, Inc.
 Abound Bio, Inc. BiotechnologyHealth Technology Part of Galapagos NV, Abound Bio, Inc. is a biotechnology company based in Pittsburgh, PA. The company's mission is to generate novel antibody-based biological therapeutics to meet unmet medical needs in the fields of cancer and infectious diseases. Abound Bio's industry-leading human antibody libraries offer size, diversity, and developability advantages that incorporate different binder formats into appropriate therapeutic platforms. The company was founded by Dimiter Dimitrov and John Mellors, with John Mellors serving as CEO since incorporation. Abound Bio was acquired by Galapagos NV on June 21, 2022 for $14 million. | Chief Executive Officer | - |
Former positions of John Mellors
| Companies | Position | End |
|---|---|---|
Infectious Disease Connect, Inc.
 Infectious Disease Connect, Inc. Specialty TelecommunicationsCommunications Infectious Disease Connect, Inc. engages in the provision of telemedicine services to hospitals. It offers IL?M Insight which provides virtual stewardship and tele-infection prevention and control. The company was founded by Rima Abdel-Massih and John Mellors in 2013 and is headquartered in Pittsburgh, PA. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Infectious Disease Connect, Inc.
Infectious Disease Connect, Inc. Specialty TelecommunicationsCommunications Infectious Disease Connect, Inc. engages in the provision of telemedicine services to hospitals. It offers IL?M Insight which provides virtual stewardship and tele-infection prevention and control. The company was founded by Rima Abdel-Massih and John Mellors in 2013 and is headquartered in Pittsburgh, PA. | Communications |
Abound Bio, Inc.
Abound Bio, Inc. BiotechnologyHealth Technology Part of Galapagos NV, Abound Bio, Inc. is a biotechnology company based in Pittsburgh, PA. The company's mission is to generate novel antibody-based biological therapeutics to meet unmet medical needs in the fields of cancer and infectious diseases. Abound Bio's industry-leading human antibody libraries offer size, diversity, and developability advantages that incorporate different binder formats into appropriate therapeutic platforms. The company was founded by Dimiter Dimitrov and John Mellors, with John Mellors serving as CEO since incorporation. Abound Bio was acquired by Galapagos NV on June 21, 2022 for $14 million. | Health Technology |
- Stock Market
- Insiders
- John Mellors
